Table 1

Demographic and clinical characteristics of the study cohort

VariableNumbers with data
Total, men/women
Total (N=8699)Men (N=5292)Women (N=3407)X2 test p value (male/female differences)
Age groups
 <408699, 5292/34071016 (11.7)625 (11.8)391 (11.5)0.635
 40–492288 (26.3)1385 (26.2)903 (26.5)0.731
 50–592815 (32.3)1728 (32.6)1087 (31.9)0.466
 60+2580 (29.7)1554 (29.3)1026 (30.1)0.558
Socioeconomic status
 Low6346, 3766/25802239 (35.3)1345 (35.7)894 (34.6)0.384
 Middle2516 (39.6)1499 (39.8)1017 (39.4)0.758
 High1591 (25.1)922 (24.5)669 (25.9)0.191
Diabetes duration (year)
 <25081, 3027/2054948 (18.6)554 (18.3)394 (19.2)0.429
 2–52263 (44.5)1340 (44.2)923 (44.9)0.638
 >51870 (36.8)1133 (37.4)737 (35.9)0.261
Smoking/tobacco use7695, 4678/30171633 (21.2)1201 (25.6)432 (14.3)<0.001
Physical activity7029, 4372/26573150 (44.8)2122 (48.5)1028 (38.7)<0.001
Obesity, BMI≥25 kg/m28699, 5292/34073070 (35.3)1773 (33.5)1293 (37.9)<0.001
Hypertension8673, 5275/33984464 (51.5)2583 (48.9)1881 (55.3)<0.001
Cholesterol ≥200 mg/dL3979, 2469/15101390 (34.9)824 (33.4)566 (37.5)0.008
LDL cholesterol ≥100 mg/dL3979, 2469/15101989 (50.0)1193 (48.3)796 (52.7)0.007
Triglycerides ≥150 mg/dL3979, 2469/15101403 (35.2)866 (35.0)537 (35.5)0.754
HDL<40/50 mg/dL3979, 2469/15101945 (48.9)1025 (41.5)920 (60.9)0.001
Macrovascular complications
 Coronary heart disease7131, 4391/27401099 (15.4)720 (16.4)379 (13.8)0.003
 Others (stroke, PAD)372 (5.2)232 (8.5)140 (5.1)0.743
Microvascular diseases
 Retinopathy4851, 2992/1859298 (6.1)183 (6.1)115 (6.1)0.994
 Others670 (13.9)424 (14.2)246 (13.2)0.357
Hypothyroidism5423, 3289/2134500 (9.2)222 (6.7)278 (13.0)<0.001
Chronic renal disease (serum creatinine ≥2.0 mg/dL)6381, 3915/2466356 (5.6)267 (6.8)89 (3.6)<0.001
  • Numbers in parentheses are percent.

  • BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PAD, peripheral arterial disease.